Lilabsh Animal Genetics And Cryogenics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
About Lilabsh Animal Genetics And Cryogenics
Lilabsh Animal Genetics And Cryogenics Private Limited (LAGACPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2019 (Five years and 11 months 26 days old ). Its registered office is in Banaskantha, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Lilaben Patel and Rameshkumar Chaudhary serve as directors at the Company.
Company Details
-
Location
Banaskantha, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01114GJ2019PTC106591
-
Company No.
106591
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Feb 2019
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Lilabsh Animal Genetics And Cryogenics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lilaben Patel
|
Director | 13-Feb-2019 | Current |
|
Rameshkumar Chaudhary
|
Director | 13-Feb-2019 | Current |
Financial Performance of Lilabsh Animal Genetics And Cryogenics.
Lilabsh Animal Genetics And Cryogenics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lilabsh Animal Genetics And Cryogenics?
Unlock access to Lilabsh Animal Genetics And Cryogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lilabsh Animal Genetics And Cryogenics?
Unlock and access historical data on people associated with Lilabsh Animal Genetics And Cryogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lilabsh Animal Genetics And Cryogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lilabsh Animal Genetics And Cryogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.